Cargando…

Folic Acid Modulates Matrix Metalloproteinase-9 Expression Following Spinal Cord Injury

BACKGROUND: Treatment of spinal cord injury (SCI) induced neuropathic pain (NP) proves to be extremely clinically challenging as the mechanism behind SCINP is poorly understood. Matrix metalloproteinase (MMP) is largely responsible for the early disruption of the blood spinal cord barrier. This syst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miranpuri, Gurwattan S, Nguyen, Justyn, Moreno, Neydis, Yutuc, Noemi A, Kim, Jason, Buttar, Seah, Brown, Greta R, Sauer, Sydney E, Singh, Chandra K, Kumar, Saurabh, Resnick, Daniel K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Indian Academy of Neurosciences 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894625/ https://www.ncbi.nlm.nih.gov/pubmed/31975775 http://dx.doi.org/10.5214/ans.0972.7531.260205

Ejemplares similares

Role of Microglia and Astrocytes in Spinal Cord Injury Induced Neuropathic Pain
por: Miranpuri, Gurwattan S., et al.
Publicado: (2021)

Role of Matrix Metalloproteinases 2 in Spinal Cord Injury-Induced Neuropathic Pain
por: Miranpuri, Gurwattan S., et al.
Publicado: (2016)

Novel targets for Spinal Cord Injury related neuropathic pain
por: Ahmed, Mostafa M, et al.
Publicado: (2011)

In Vivo application of RNAi to study pain
por: Clark, Zachary J, et al.
Publicado: (2010)

Emerging role of WNK1 in pathologic central nervous system signaling
por: Krueger, Evan M., et al.
Publicado: (2011)

The role of cation-dependent chloride transporters in neuropathic pain following spinal cord injury
por: Cramer, Samuel W, et al.
Publicado: (2008)

Pathogenesis of spinal cord injury induced edema and neuropathic pain: expression of multiple isoforms of wnk1
por: Ahmed, Mostafa M., et al.
Publicado: (2014)

Neuropathic pain: role of inflammation, immune response, and ion channel activity in central injury mechanisms
por: Schomberg, Dominic, et al.
Publicado: (2012)

The multifunctional and multi-system influence of Ghrelin in the treatment of diabetic and spinal cord injury induced Neuropathy
por: Fields, DP, et al.
Publicado: (2011)

The Substitute Brain and the Potential of the Gel Model
por: Pomfret, Roland, et al.
Publicado: (2013)

Investigation of the electrical properties of agarose gel: characterization of concentration using nyquist plot phase angle and the implications of a more comprehensive in vitro model of the brain
por: Pomfret, Roland, et al.
Publicado: (2013)

Altered Expression of Heat Shock Protein-27 and Monocyte Chemoattractant Protein-1 after Acute Spinal Cord Injury: A Pilot Study
por: Boraiah, Vidyasagar, et al.
Publicado: (2019)

Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury
por: Buss, Armin, et al.
Publicado: (2007)

A nutrient mixture reduces the expression of matrix metalloproteinases in an animal model of spinal cord injury by modulating matrix metalloproteinase-2 and matrix metalloproteinase-9 promoter activities
por: ZHANG, HONGQI, et al.
Publicado: (2014)

Role of Matrix Metalloproteinases and Therapeutic Benefits of Their Inhibition in Spinal Cord Injury
por: Zhang, Haoqian, et al.
Publicado: (2011)

Ramped-rate vs continuous-rate infusions: An in vitro comparison of convection enhanced delivery protocols
por: Schomberg, Dominic, et al.
Publicado: (2013)

Downregulation of Matrix Metalloproteinases 2 and 9 is Involved in the Protective Effect of Trehalose on Spinal Cord Injury
por: Mirzaie, Masoumeh, et al.
Publicado: (2018)

Thermal stability of human matrix metalloproteinases
por: Meraz-Cruz, Noemi, et al.
Publicado: (2020)

Convection enhanced delivery to the Brain: preparing for gene therapy and protein delivery to the Brain for functional and restorative Neurosurgery by understanding low-flow neurocatheter infusions using the Alaris(®) system infusion pump
por: Sillay, Karl, et al.
Publicado: (2013)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Multifaceted role of matrix metalloproteinases (MMPs)
por: Singh, Divya, et al.
Publicado: (2015)

Matrix metalloproteinases and epileptogenesis
por: Ikonomidou, Chrysanthy
Publicado: (2014)

Matrix Metalloproteinases and Glaucoma
por: Kim, Moo Hyun, et al.
Publicado: (2022)

Water treadmill training attenuates blood-spinal cord barrier disruption in rats by promoting angiogenesis and inhibiting matrix metalloproteinase-2/9 expression following spinal cord injury
por: Ying, Xinwang, et al.
Publicado: (2020)

Efficacy of a Metalloproteinase Inhibitor in Spinal Cord Injured Dogs
por: Levine, Jonathan M., et al.
Publicado: (2014)

5‐Fluorouracil reduces the fibrotic scar via inhibiting matrix metalloproteinase 9 and stabilizing microtubules after spinal cord injury
por: Xu, Yang, et al.
Publicado: (2022)

Gene-based therapy of Parkinson’s Disease: Translation from animal model to human clinical trial employing convection enhanced delivery
por: Miranpuri, Gurwattan S., et al.
Publicado: (2012)

Matrix Metalloproteinases in Cerebral Ischemia
por: Kim, Hahn Young, et al.
Publicado: (2006)

Matrix metalloproteinases in arthritic disease
por: Murphy, Gillian, et al.
Publicado: (2002)

Matrix metalloproteinases in lung biology
por: Parks, William C, et al.
Publicado: (2001)

Matrix metalloproteinases in exercise and obesity
por: Jaoude, Jonathan, et al.
Publicado: (2016)

Matrix Metalloproteinases and Glaucoma Treatment
por: Weinreb, Robert N., et al.
Publicado: (2020)

Challenges in Matrix Metalloproteinases Inhibition
por: Laronha, Helena, et al.
Publicado: (2020)

Matrix Metalloproteinases in Health and Disease
por: Serra, Raffaele
Publicado: (2020)

Matrix metalloproteinases in keratinocyte carcinomas
por: Riihilä, Pilvi, et al.
Publicado: (2020)

Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissuenhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase
por: Collins, H M, et al.
Publicado: (2001)

Circulating Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Cardiac Amyloidosis
por: Tanaka, Komei, et al.
Publicado: (2013)

Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6q9sa0talv351h7lcem84cr055